Quarterly results of companies in the week of 27.3. - 31.3.: Walgreens Boots Alliance, EVGO, Jefferies
Many companies are reporting their results this week, unfortunately they are mostly lesser known companies, so I don't have many favorites here. But if we look at the most interesting ones, we see Walgreens and Jefferies, for example.

Earnings season from 27.3. - 31.3.
I take Biontech $BNTX, Walgreens Boots Alliance $WBA, Micron $MU, Kingsoft Cloud Holdings $KC, EVGO $EVGO Jefferies $JEF as the most interesting companies of the week.
What do analysts expect from these companies?
Biontech $BNTX
For the next quarter, the company is expected to report earnings of $8.68 per share, reflecting a 37.69% year-over-year decline in revenue and net income.
Walgreens Boots Alliance $WBA
The largest U.S. drugstore chain is expected to post quarterly earnings of $1.10 per share in its upcoming report, representing a year-over-year change of -30.8%. Revenue is expected to be $33.45 billion, down 0.9% from the previous quarter.
Micron $MU
This chip maker is expected to report a quarterly loss of $0.65 per share in its upcoming report, representing a year-over-year change of -130.4%. Revenue is expected to be $3.78 billion, down 51.4% from the previous quarter.
Kingsoft Cloud Holdings $KC
According to Zacks Investment Research, the consensus EPS forecast for the quarter is -0.29 on declining revenue and net income.
EVGO $EVGO
According to Zacks Investment Research, based on 2 analyst forecasts, the consensus EPS forecast for the quarter is $-0.14. Reported earnings per share for the same quarter last year were $0.06.
Jefferies $JEF
This investment banking and capital markets firm is expected to post quarterly earnings at $0.58 per share in its upcoming report, representing a year-over-year change of -53.2%. Revenue is expected to be $1.21 billion, down 30.1% from the previous quarter.
Whose results do you care about? Let me know in the comments!
If you'd like to share this graphic, you can download it HERE.
Ta članek je bil napisan in pregledan v skladu z uredniškimi standardi Bulios.
Spremljajte Bulios na Google Novicah
Bodite med prvimi, ki izveste za nove analize, novice in premike na trgih.
Priporočeni članki